Lisa F Lincz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Aortic Dissection

Extracorporeal Membrane Oxygenation

Top Venues

International journal of molecular sciences

Journal of circulating biomarkers

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa F Lincz, Danielle Z Theron, Daniel L Barry, Fiona E Scorgie, Jonathan Sillar, Opelo Sefhore, Anoop K Enjeti, Kathryn A Skelding
High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia. Cancers 16 (5) (2024)
Lisa F Lincz, Danielle Z Theron, Daniel L Barry, Fiona E Scorgie, Jonathan Sillar, Opelo Sefhore, Anoop K Enjeti, Kathryn A Skelding
High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia. Cancers 16 (5) (2024)
Lisa F Lincz, Karan Makhija, Khaled Attalla, Fiona E Scorgie, Anoop K Enjeti, Ritam Prasad
A comparative evaluation of three consecutive artificial intelligence algorithms released by Techcyte for identification of blasts and white blood cells in abnormal peripheral blood films. International journal of laboratory hematology (2023)
Kathryn A Skelding, Daniel L Barry, Danielle Z Theron, Lisa F Lincz
Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia. International journal of molecular sciences 24 (1) (2022)
Kathryn A Skelding, Daniel L Barry, Danielle Z Theron, Lisa F Lincz
Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia. International journal of molecular sciences 24 (1) (2022)
Kathryn A Skelding, Daniel L Barry, Danielle Z Theron, Lisa F Lincz
Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia. International journal of molecular sciences 24 (1) (2022)
Kathryn A Skelding, Daniel L Barry, Danielle Z Theron, Lisa F Lincz
Targeting the two-pore channel 2 in cancer progression and metastasis. Exploration of targeted anti-tumor therapy 3 (1) (2022)
Kathryn A Skelding, Lisa F Lincz
PARP Inhibitors and Haematological Malignancies-Friend or Foe? Cancers 13 (21) (2021)
Elizabeth G Holliday, Thomas Lillicrap, Timothy Kleinig, Philip M C Choi, Jane Maguire, Andrew Bivard, Lisa F Lincz, Monica Anne Hamilton-Bruce, Sushma R Rao, Marten F Snel, Paul J Trim, Longting Lin, Mark W Parsons, Bradford B Worrall, Simon A Koblar, John Richard Attia, Chris Levi
Developing a multivariable prediction model for functional outcome after reperfusion therapy for acute ischaemic stroke: study protocol for the Targeting Optimal Thrombolysis Outcomes (TOTO) multicentre cohort study. BMJ open 10 (4) (2020)
Lisa F Lincz, Fiona E Scorgie, Madhu B Garg, Jayne Gilbert, Jennette A Sakoff
A simplified method to calculate telomere length from Southern blot images of terminal restriction fragment lengths. BioTechniques 68 (1) (2019)
Mohammad J Alkhatatbeh, Anoop K Enjeti, Sara Baqar, Elif I Ekinci, Dorothy Liu, Rick F Thorne, Lisa F Lincz
Strategies for enumeration of circulating microvesicles on a conventional flow cytometer: Counting beads and scatter parameters. Journal of circulating biomarkers 7 (2018)